Page last updated: 2024-08-16

propidium and ganciclovir

propidium has been researched along with ganciclovir in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Belldegrun, A; Berger, F; Black, ME; Gambhir, SS; Matherly, J; Nguyen, D; Pantuck, AJ; Wu, L; Zisman, A	1
Hakkarainen, T; Loimas, S; Parkkinen, J; Pasanen, T; Tenhunen, A; Timonen, P; Wahlfors, J	1

Other Studies

2 other study(ies) available for propidium and ganciclovir

Article	Year
Optimizing prostate cancer suicide gene therapy using herpes simplex virus thymidine kinase active site variants. Human gene therapy, 2002, May-01, Volume: 13, Issue:7 Topics: Acyclovir; Animals; Antiviral Agents; Apoptosis; Binding Sites; Blotting, Southern; Blotting, Western; Disease Progression; Dose-Response Relationship, Drug; Flow Cytometry; Ganciclovir; Genetic Therapy; Green Fluorescent Proteins; Guanosine; Humans; Luminescent Proteins; Male; Mice; Mice, SCID; Mutation; Neoplasm Metastasis; Neoplasm Transplantation; Prodrugs; Propidium; Prostatic Neoplasms; Simplexvirus; Tetrazolium Salts; Thiazoles; Thymidine Kinase; Tomography, Emission-Computed; Tumor Cells, Cultured	2002
TK-GFP fusion gene virus vectors as tools for studying the features of HSV-TK/ganciclovir cancer gene therapy in vivo. International journal of molecular medicine, 2003, Volume: 12, Issue:4 Topics: Animals; Antiviral Agents; Cell Line, Tumor; Flow Cytometry; Ganciclovir; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Green Fluorescent Proteins; Humans; Lentivirus; Luminescent Proteins; Neoplasms; Propidium; Rats; Simplexvirus; Thymidine Kinase; Time Factors; Transgenes	2003

Article

Year

Optimizing prostate cancer suicide gene therapy using herpes simplex virus thymidine kinase active site variants.

Human gene therapy, 2002, May-01, Volume: 13, Issue:7

Topics: Acyclovir; Animals; Antiviral Agents; Apoptosis; Binding Sites; Blotting, Southern; Blotting, Western; Disease Progression; Dose-Response Relationship, Drug; Flow Cytometry; Ganciclovir; Genetic Therapy; Green Fluorescent Proteins; Guanosine; Humans; Luminescent Proteins; Male; Mice; Mice, SCID; Mutation; Neoplasm Metastasis; Neoplasm Transplantation; Prodrugs; Propidium; Prostatic Neoplasms; Simplexvirus; Tetrazolium Salts; Thiazoles; Thymidine Kinase; Tomography, Emission-Computed; Tumor Cells, Cultured

2002

TK-GFP fusion gene virus vectors as tools for studying the features of HSV-TK/ganciclovir cancer gene therapy in vivo.

International journal of molecular medicine, 2003, Volume: 12, Issue:4

Topics: Animals; Antiviral Agents; Cell Line, Tumor; Flow Cytometry; Ganciclovir; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Green Fluorescent Proteins; Humans; Lentivirus; Luminescent Proteins; Neoplasms; Propidium; Rats; Simplexvirus; Thymidine Kinase; Time Factors; Transgenes

2003